Video
Let's talk antitrust: Discussing recent cases and emerging competition issues
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Author:
Global | Publication | May 2016
Instrument: “Case Management Guidelines for NOC Applications”, further to the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 (as am.) (the Regulations)
Date released: Presented 12 May 2016 at CBA IP Day Town Hall; on the Federal Court website 20 May 2016
The Federal Court has introduced new guidelines for the case-management of prohibition applications under the Regulations. The new guidelines were presented by Chief Justice Crampton, Justice Manson, and Prothonotary Tabib at the Canadian Bar Association’s 2016 IP Day Town Hall meeting. They build upon a practice direction that has been in effect for proceedings of this kind since 7 January 2008 and outline procedures that emphasise early scheduling, strict time management, narrowing of issues, and limiting the amount of material to be reviewed by hearing judges. They also introduce a general rule that all Federal Court cases (including infringement/impeachment and section 8 actions) will be heard on a fixed-end basis.
As explained at the Town Hall, these guidelines are effective immediately and apply to all new prohibition applications, as well as ongoing matters provided they are early enough in the process.
The new guidelines are not absolute, but will be applied by case-management and hearing judges in the absence of exceptional reasons for departing from this approach. In part, they reiterate the process already defined by the Regulations and familiar to litigants today. Among the new policies introduced, the following are highlights:
To access a complete copy of the new guidelines, as well as the previous practice direction, follow the links below.
Link to guidelines:
Notice to the Parties and Profession (May 2016): Case Management Guidelines for NOC Applications
Notice to the Parties and Profession (7 December 2007): Practice Direction — NOC Proceedings
Video
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Publication
After a lacklustre finish to 2022 when compared to the vintage year for M&A that was 2021, dealmakers expected 2023 to see the market continue to cool in most sectors, in response to the economic headwinds of rising inflation (with its corresponding impact on financing costs), declining market valuations, tightening regulatory scrutiny and increasing geopolitical tensions.
Publication
On 18 September 2023, the CMA published its Initial Report (Initial Report) on AI Foundation Models (FM), supplemented in April 2024 with the publication of its “Update Paper” focused on potential antitrust risks associated with FMs and a “Technical Update Report” providing more detail on the development on FMs (collectively the “Reports”). Below, we consider these CMA publications.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023